Evidence map›Paper›PMID 25706406›Full record

ArticleACS chemical biology2015

Rapid synthesis, RNA binding, and antibacterial screening of a peptidic-aminosugar (PA) library.

Liuwei Jiang, Derrick Watkins, Yi Jin, Changjun Gong, Ada King, Arren Z Washington, Keith D Green, Sylvie Garneau-Tsodikova, Adegboyega K Oyelere, Dev P Arya

Abstract read
In one paragraph

Article in ACS chemical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. New 3,4-International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Liuwei Jiang†Laboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
Derrick Watkins‡NUBAD, LLC, Greenville, South Carolina 29605, United States.
Yi Jin†Laboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
Changjun Gong†Laboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
Ada King‡NUBAD, LLC, Greenville, South Carolina 29605, United States.
Arren Z Washington§School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Keith D Green∥College of Pharmacy, Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536-0596, United States.
Sylvie Garneau-Tsodikova∥College of Pharmacy, Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536-0596, United States.
Adegboyega K Oyelere§School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Dev P Arya†Laboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.

Funding

Novel aminoglycoside adjuvants and stand-alone agents to combat tuberculosisR01AI090048 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARNEAU-TSODIKOVA, SYLVIE · 2011 to 2021
$4.4M
A Rapid assay for RNA targeted drugs: Instrumentation SupplementR42GM097917 · NIGMS · NUBAD, LLC · PI ARYA, DEV PRIYA · 2014 to 2015
$1.4M
Targeting RNA conformation for drug developmentR41GM100607 · NIGMS · NUBAD, LLC · PI ARYA, DEV PRIYA · 2012 to 2012
$295k
A novel assay for RNA targeted drugsR41GM097917 · NIGMS · NUBAD, LLC · PI ARYA, DEV PRIYA · 2011 to 2011
$286k
NIAID NIH HHS 1R01AI090048NIAID NIH HHS R01 AI090048NIGMS NIH HHS 1R41GM100607NIGMS NIH HHS 2R42GM100607NIGMS NIH HHS R41 GM097917NIGMS NIH HHS R41 GM100607NIGMS NIH HHS R42 GM097917
6 · The paper itself

Abstract

A 215-member mono- and diamino acid peptidic-aminosugar (PA) library, with neomycin as the model aminosugar, was systematically and rapidly synthesized via solid phase synthesis. Antibacterial activities of the PA library, on 13 bacterial strains (seven Gram-positive and six Gram-negative bacterial strains), and binding affinities of the PA library for a 27-base model of the bacterial 16S ribosomal A-site RNA were evaluated using high-throughput screening. The results of the two assays were correlated using Ribosomal Binding-Bacterial Inhibition Plot (RB-BIP) analysis to provide structure-activity relationship (SAR) information. From this work, we have identified PAs that can discriminate the E. coli A-site from the human A-site by up to a 28-fold difference in binding affinity. Aminoglycoside-modifying enzyme activity studies indicate that APH(2″)-Ia showed nearly complete removal of activity with a number of PAs. The synthesis of the compound library and screening can both be performed rapidly, allowing for an iterative process of aminoglycoside synthesis and screening of PA libraries for optimal binding and antibacterial activity for lead identification.

Indexed as

Peptide LibraryAmino SugarsAnti-Bacterial AgentsBacteriaCarbohydrate SequenceHigh-Throughput Screening AssaysMicrobial Sensitivity TestsMolecular Sequence DataRNAStructure-Activity RelationshipAmino SugarsAnti-Bacterial AgentsPeptide LibraryRNA

Identifiers

PMID25706406
PMCPMC4837463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.